www.fdanews.com/articles/122775-phase-iii-trial-of-z-036-fails-to-meet-primary-endpoint

Phase III Trial of Z-036 Fails to Meet Primary Endpoint

December 7, 2009

AEterna Zentaris Inc. reported Phase 3 results for its European efficacy trial Z-036 in benign prostatic hyperplasia, with cetrorelix pamoate.
TradingMarkets